Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma

Langenbeck's Archives of Surgery

Volumn 384, Issue 3, 1999, Pages 271-276

  Machens, Andreas ^a   Gimm, Oliver ^a   Ukkat, Jörg ^a   Sutter, Thomas ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Lymph node dissection; Medullary thyroid carcinoma; Palliation; Resternotomy

Indexed keywords

CALCITONIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PALLIATIVE THERAPY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MEDIASTINUM LYMPH NODE; MORTALITY; PRIORITY JOURNAL; REOPERATION; STERNOTOMY; THYROID MEDULLARY CARCINOMA;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; MIDDLE AGED; PALLIATIVE CARE; REOPERATION; SURVIVAL RATE; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032988830     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050203     Document Type: Article

References (23)

1. Tisell LE, Hansson G, Jansson S, Salander H (1986) Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99:60-66
2. Van Heerden JA, Grant CS, Gharib H, Hay JD, Ilstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212: 395-400
3. Moley JF, Wells SA, Dilley WG, Tisell LE (1993) Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 114:1090-1095
4. Dralle H, Damm I, Scheumann GFW, Kotzerke J, Kupsch E, Geerlings H, et al (1994) Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24:112-121
5. Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L (1996) Multivariate analysis of patients with medullary thyroid carcinoma - prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556-1565
6. Gimm O, Ukkat J, Dralle H (1998) Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 22:562-567
7. Buhr HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C (1993) Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer 72:3685-3693
8. Ellenhorn JD, Shah JP, Brennan MF (1993) Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery 114:1078-1081
9. Marzano LA, Porcelli A, Biondi B, Lupoli G, Delrio P, Lombardi G, et al (1995) Surgical management and follow-up of medullary thyroid carcinoma. J Surg Oncol 59:162-168
10. Sobin LH, Wittekind Ch (eds) (1997) TNM classification of malignant tumours. Wiley, New York
11. Dralle H, Scheumann GF, Proye C, Bacourt F, Frilling A, Limbert F, et al (1995) The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 238:357-361
12. Bergholm U, Adami HO, Bergström R, Johansson H, Lundell G, Telenius-Berg M, et al (1989) Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nation wide study of 249 patients in Sweden from 1959 through 1981. Cancer 63:1196-1204
13. Längle F, Soliman T, Neuhold N, Widhalm G, Niederle B, Roka S, et al (1994) CA15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria. World J Surg 18:583-587
14. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herfarth C (1993) Medullary carcinoma of the thyroid-therapeutic strategy derived from fifteen years of experience. Surgery 114:491-496
15. Brunt LM, Wells SA (1987) Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg Clin North Am 67:263-279
16. Schröder S, Böcker W, Baisch H, Bürk CG, Arps H, Meiners I, et al (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806-816
17. Gautvik KM, Talle K, Hager B, Jorgensen OG, Aas M (1989) Early liver metastases in patients with medullary carcinoma of the thyroid gland. Cancer 63:175-180
18. Chen H, Roberts JR, Ball DW, Eisele DW, Baylin SB, Udelsman R, et al (1998) Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg 227:887-895
19. Sandrock D, Blossey HC, Steinroeder M, Munz DL (1989) Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma. Henry Ford Hosp Med J 37:173-174
20. Frank-Raue K, Bihl H, Dörr U, Buhr H, Ziegler R, Raue F (1995) Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol 42:31-37
21. Learoyd DL, Roach PJ, Briggs GM, Delbridge LW, Wilmshurst EG, Robinson BG (1997) Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma. J Nucl Med 38:227-230
22. Abdelmoumene N, Schlumberger M, Gardet P, Roche A, Travagli JP, Francese C, et al (1994) Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer 69:1141-1144
23. Moley JF, Dilley WG, DeBenedetti MK (1997) Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg 225:734-740